Navigation Links
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis

- Anti-IL-2 receptor antibody significantly reduced the number of new or enlarged lesions compared to placebo; data to be submitted for presentation at upcoming medical meeting -

CAMBRIDGE, Mass. and FREMONT, Calif., March 12, 2007 /PRNewswire-FirstCall/ -- Biogen Idec, Inc. and PDL BioPharma, Inc. (PDL) announced today that the ongoing CHOICE trial, a Phase 2, randomized, double-blind, placebo-controlled trial of daclizumab, met its primary endpoint in relapsing multiple sclerosis (MS) patients being treated with interferon beta. Patients receiving daclizumab 2 mg/kg subcutaneously every 2 weeks showed a significant reduction in the number of new or enlarged gadolinium-contrast-enhancing lesions (Gd-CELs) at week 24.

Daclizumab is a humanized monoclonal antibody that targets the IL-2 receptor on activated T cells. Study results will be submitted for presentation at an upcoming medical meeting later this year. Based on a joint review of the 24-week data, the companies plan to initiate a Phase 2 monotherapy trial of daclizumab, and to advance the overall clinical development program in relapsing MS.

"We are very pleased to see positive results from the first randomized trial of daclizumab in patients with relapsing MS, and we look forward to advancing the clinical development program with our partner and acknowledged leader in the MS field, Biogen Idec," said Mark A. McCamish, M.D., Ph.D., chief medical officer, PDL BioPharma. "While the week 24 data set will be presented later this year, we are planning to move forward with additional development activities, most notably the initiation of the SELECT trial, which will study daclizumab as a single agent in patients with relapsing MS."

"We congratulate PDL on conducting a successful trial of daclizumab in MS," said Al Sandrock, M.D., Ph.D., senior vice president, neurology research and development, Biogen Idec. "Daclizumab represents an exciti
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. ENDEAVOR IV Clinical Trial Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
5. Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint
6. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
7. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
8. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
9. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
10. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
11. Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints

Post Your Comments:
(Date:11/7/2009)...re/ -- Patients reported C1-esterase inhibitor (C1...ing acute swelling attacks at any body location fo...ing to data presented today at the 2009 American C... Annual Meeting. The results come from a self-repo... the ongoing, prospective, open label I nternatio...
(Date:11/6/2009)...Call/ -- Recession in domestic and international m...hcare Products in the first quarter of fiscal year...nes pushed Allied into a loss for the quarter. Th...negative 9 cents per share, compared to a net prof...per share. ,, Sales fell about 21 percent in t...
(Date:11/6/2009)...e-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE...ny, announced today that Paul Bisaro, Watson,s pre...n overview and update of the Company,s business at...ce on Wednesday, November 11, 2009 at 12:00 pm Eas...e webcast live and can be accessed on Watson Pharm...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Computer modeling shows strategies to rein in epidemics need to be retooled for rural populations 47653 1Computer modeling shows strategies to rein in epidemics need to be retooled for rural populations 47653 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 1Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 1Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 2Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 4
(Date:11/8/2009)...etwork (MHN) urges military veterans to learn abou...xposure to chemicals, atomic agents and soot or sm...f those cancers that is two times more prevalent i...rrently smoke cigarettes. , ...squo;s Health Network (MHN) kicked-off their Veter...
(Date:11/8/2009)...e/ -- Today, the House of Representatives passed t...orth and Lipinski amendment to the "Affordable Hea...nt maintains the current policy of preventing fede... that include abortion. It clarifies that individu...and those who do not, can with their own funds pur...
(Date:11/8/2009)...alth advocates committed to achieving meaningful h...7 "Tonight the U.S. Hou...oice of America,s families by passing the Affordab...t deliver, without delay, on the promise of meanin..., President and CEO of the National Alliance for H...
(Date:11/8/2009)...e/ -- Pharmaceutical Research and Manufacturers of... released the following statement regarding the Ho...inted, but not surprised by today,s vote -- an une...s as well as nearly half of the members of the U.S...ill. ,, "While well intentioned, the bill -- as...
(Date:11/8/2009)...e/ -- The following was released today by Randall ... ,, Mr. Terry and his associates from around th... by abortion out of any health care bill for month...step to victory -- a touchdown in the first quarte...r rejoicing must be tempered by reality. The Senat...
Breaking Medicine News(10 mins):Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3
...ng a body mass index (BMI) in the overweight or ob...e injury , thus employer-sponsored weight loss and... of a well-rounded workplace safety plan. ...ding to the Centres for Disease Control and Preven...
...of small breast cancer may be a safe procedure ass...tisfaction , according to a recent case report by ...al. The report presents a case of an 85-ye..., lead author of the report. In all but one publis...
...ly 100% detection rate in acute ruptured, cerebral...at the Health Sciences Center in Winnipeg, Canada... acute subarachnoid hemorrhage (SAH) who underwent...ad author of the study. Of the 22 cases where ther...
...d have found that the United States, which has the...last among other major rich countries for quality...S healthcare is consistently inferior in performan... Says Commonwealth Fund president and American ci...
...search, there is still hope for the couch potatoes...director of the Laboratory of Preventive Medicine ...ter at Louisiana State University, shows that even...ch published in the Journal of the American Medica...
...nd rising sea levels. Both of these are effects of... activity is changing our climate at a rate well ...ow the Earths climate system works and responds to... more about the natural cycles. This will enable u...
Other Medicine News:Health News:Risk of Traumatic Workplace Injury Increased by Obesity 2Health News:CTA Useful in Detecting Ruptured Cerebral Aneurysms 2Health News:Americans Get Least Value For Money In Healthcare 2Health News:Spare Just Ten Minutes A Day For A Healthier Heart 2Health News:Investigating Coral Reefs to Help Understand Past and Future Climate Change 2
...the market today. The horseshoe evaporator ensures...rain channels away moisture for continual defrost ...ugh, baked-on epoxy paint finish and the textured ...igerator is constructed of vacuum molded, high-imp...
...pH and temperature measurements. Temperature compe... temperature probe (ATC) or a 3-in-1 electrode. &b...ith Auto-Find automatic buffer recognition for fiv...nd Auto-Read for locking onto stable readings. &bu...
...pH and temperature measurements. Temperature compe... temperature probe (ATC) or a 3-in-1 electrode. &b...ith Auto-Find automatic buffer recognition for fiv...nd Auto-Read for locking onto stable readings. &bu...
...pH and temperature measurements. Temperature compe... temperature probe (ATC) or a 3-in-1 electrode. &b...ith Auto-Find automatic buffer recognition for fiv...nd Auto-Read for locking onto stable readings. &bu...
Medicine Products: